Senior insider sale
Chief Executive Officer at GALECTIN THERAPEUTICS INC — senior position signals high conviction
$150.9K
30K shares
What this filing means
SHLEVIN HAROLD H. plans to sell 30K shares of GALECTIN THERAPEUTICS INC valued at approximately $150.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/29/2026ACC: 0001628280-26-045997
Officer· Chief Executive Officer
Since Jan 2019
30K
Shares to sell
$150.9K
Approx. market value
22.27K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
STOCK OPTION EXERCISE
CASH UPON EXERCISE
1/23/2025
22.27KTotal acquired22.27K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/23/2025 | STOCK OPTION EXERCISE CASH UPON EXERCISE | 22.27K | — |
| Total | 22.27K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
7.73K
Market value
$38.7K
6/26/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
22.27K
Market value
$112.2K
6/29/2026
Total
Units
30K
Value
$150.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/26/2026 | 7.73K | $38.7K | — | Completed |
| Planned — Approximate Date | ||||
6/29/2026 | 22.27K | $112.2K | NASDAQ | Planned |
| Total | 30K | $150.9K | ||